Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03573947
Title Phase II Clinical Trial of NIVO-IPI-TAXANE in Untreated Metastatic NSCLC (TOP1705)
Acronym TOP1705
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jeffrey Clarke
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.